Clinical Trials Browser

Phase 2 × Neuroma, Acoustic × 1 year × Clear all

Ependymoma, Meningioma, Neuroma, Acoustic, Neurofibromatosis 2

NCT06322342 2025-12-26

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Neuroinflammatory Diseases, Brain Neoplasms, Glioma, Meningioma, Multiple Sclerosis, Neoplasms, Neurilemmoma, Neurofibroma, Neuroma, Acoustic, Central Nervous System Neoplasms

NCT03079999 2025-12-18

Study of Aspirin in Patients With Vestibular Schwannoma

Phase 2 Active not recruiting

97 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT01199978 2025-10-01

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Phase 2 Active not recruiting

30 enrolled

CNS

Neuroma, Acoustic

NCT04743310 2025-06-13

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Phase 2 Completed

50 enrolled

CNS

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Neuroma, Acoustic, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Clinical Trials

INTUITT-NF2

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Study of Aspirin in Patients With Vestibular Schwannoma

Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System